榴莲直播

About Asma Ali

Dr. Asma Ali is an Assistant Professor a PI of the Pharmacy and Health Systems Research and Management Innovation Lab (PHRM) in the Division of Health Systems Management and Policy. A pharmacist by training and a scientist at heart, Dr. Ali brings a unique perspective to her work, drawing from her Palestinian roots and formative years in Jordan.

Dr. Ali employs qualitative, quantitative, and observational research methods to explore the intersection of health behaviors and healthcare delivery. Her research focuses on identifying factors and self-management care that influence health outcomes of individuals with chronic conditions, including the use of digital health.

As the principal investigator on competitive university-funded grants, Dr. Ali works to bridge gaps in care quality within healthcare systems, including pharmacies and primary care clinics. Her research approach is rooted in community-based participatory research, utilizing innovative methods to enhance health outcomes, healthcare quality, and health equity. She conducts mixed-methods research projects that engage and inform stakeholders at multiple levels of the healthcare system, ultimately improving health outcomes.

Dr. Ali's dedication to mentoring has enabled a diverse group of PharmD and PhD students to gain hands-on research experience and support their career aspirations. One of her notable projects, 鈥淓xploring Lived Experiences of Diabetes Self-management Behavior and Medication Use in Muslim Patients with Type 2 Diabetes,鈥� led to the development of the patient-centered clinical assessment tool, Recognizing Access and Management Associated Diabetes Adversities in Nationwide Muslims in the US (RAMADAN) 漏. This tool aims to identify diabetes self-management challenges and improve patient-provider communication across various healthcare systems.

Dr. Ali has received several accolades, including the 2024 William E. Scheckler Outstanding Research Publication Award and the 2022 Diversity Scholar Award from AcademyHealth. Nationally, she is committed to supporting women in their professional careers, having chaired the Leadership and Professional course for the Women Interprofessional Network Group at the American Diabetes Association.

Education and Training

• T32 Postdoctoral Fellowship, Department of Family Medicine and Community Health, University of Wisconsin-Madison
• Doctor of Philosophy, Pharmaceutical Health Services, Outcomes, and Policy, University of Georgia, Athens, GA  
• PharmD, Jordan University of Science and Technology, Irbid, Jordan
• Designing a Mixed Methods Research Project Certificate, University of Michigan
• Qualitative Research: From Design to Dissemination Certificate, University of Michigan

Research Interests

Medication Use and Access in People with Chronic Conditions, Healthcare Quality, Community-Based Participatory Research, Digital Health and AI, Health Outcomes and Patient-Centered Care, Survey Design and Implementation

Selected Publications

1. Salihu EY, Omuya H, Joseph DT, Hassan JH, Ali A, Chewning B. Acceptability and Scalability of a Meditation App Among Adolescents With Type 1 Diabetes Mellitus. Cureus. 2024 Oct;16(10):e72700. doi: 10.7759/cureus.72700. eCollection 2024 Oct. PubMed PMID: 39483576; PubMed Central PMCID: PMC11527505
2. Salihu EY, Ali AM, Hassan JH, Joseph DT, Chewning B. Perspectives on Self-Management and Meditation: A Qualitative Study of Adolescents With Type 1 Diabetes Mellitus and Their Parents. Cureus. 2024 Sep;16(9):e70019. doi: 10.7759/cureus.70019. eCollection 2024 Sep. PubMed PMID: 39315319; PubMed Central PMCID: PMC11419737
3. Ali AM, Cobran EK, Young HN. Individual, interpersonal, and community factors associated with health outcomes in patients with type 2 diabetes mellitus treated at federally qualified health centers. J Diabetes Metab Disord. 2024 Jun;23(1):1071-1080. doi: 10.1007/s40200-024-01388-5. eCollection 2024 Jun. PubMed PMID: 38932882; PubMed Central PMCID: PMC11196555
4. Ali AM, Cobran EK, Young HN. Barriers Associated with Access to Prescription Medications in Patients Diagnosed with Type 2 Diabetes Mellitus Treated at Federally Qualified Health Centers. Pharmacy (Basel). 2022 Jul 8;10(4). doi: 10.3390/pharmacy10040079. PubMed PMID: 35893717; PubMed Central PMCID: PMC9326716
5. Ali AM, Young HN. Relationships between Key Functions of Patient-Provider Communication, Trust, and Motivation across White, African American, and Hispanic/Latino Patients with Asthma. Health Commun. 2022 Apr;37(4):450-456. doi: 10.1080/10410236.2020.1848758. Epub 2020 Nov 16. PubMed PMID: 33198512
6. Ali AM, Gaglioti AH, Stone RH, Crawford ND, Dobbin KK, Guglani L, Young HN. Access and Utilization of Asthma Medications Among Patients Who Receive Care in Federally Qualified Health Centers. J Prim Care Community Health. 2022 Jan-Dec;13:21501319221101202. doi: 10.1177/21501319221101202. PubMed PMID: 35603467; PubMed Central PMCID: PMC9130805